Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 5184

1.

Obesity as a Risk Factor for Unfavorable Disease in Low-risk Prostate Cancer and Its Relationship with Anatomic Location of Tumor.

Jeong IG, Yoo S, Lee C, Kim M, You D, Song C, Park S, Hong JH, Ahn H, Kim CS.

J Urol. 2017 Feb 1. pii: S0022-5347(17)30193-3. doi: 10.1016/j.juro.2017.01.073. [Epub ahead of print]

PMID:
28161349
2.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM; NRG Oncology RTOG..

N Engl J Med. 2017 Feb 2;376(5):417-428. doi: 10.1056/NEJMoa1607529.

3.

Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU).

Eredics K, Dorfinger K, Kramer G, Ponholzer A, Madersbacher S.

Wien Klin Wochenschr. 2016 Dec 21. doi: 10.1007/s00508-016-1149-8. [Epub ahead of print]

PMID:
28004265
4.

More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades.

Eifler JB, Alvarez J, Koyama T, Conwill RM, Ritch CR, Hoffman KE, Resnick MJ, Penson DF, Barocas DA; Collaborators..

J Urol. 2017 Mar;197(3 Pt 1):614-620. doi: 10.1016/j.juro.2016.10.067.

PMID:
27984110
5.

Diet, Lifestyles, Family History, and Prostate Cancer Incidence in an East Algerian Patient Group.

Lassed S, Deus CM, Lourenço N, Dahdouh A, Rizvanov AA, Oliveira PJ, Zama D.

Biomed Res Int. 2016;2016:5730569.

6.

Limiting overdiagnosis of low-risk prostate cancer through an evaluation of the predictive value of transrectal and power Doppler ultrasonography.

Sauvain JL, Sauvain E, Papavero R, Louis D, Rohmer P.

J Ultrasound. 2016 Sep 29;19(4):275-280.

PMID:
27965718
7.

New and Emerging Diagnostic and Prognostic Immunohistochemical Biomarkers in Prostate Pathology.

Giannico GA, Arnold SA, Gellert LL, Hameed O.

Adv Anat Pathol. 2017 Jan;24(1):35-44. Review.

PMID:
27941540
8.

Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.

Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y; Canary Prostate Active Surveillance Study Investigators..

Eur Urol. 2016 Nov 23. pii: S0302-2838(16)30850-8. doi: 10.1016/j.eururo.2016.11.017. [Epub ahead of print]

PMID:
27889277
9.

Active surveillance for favorable-risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review.

Ruane-McAteer E, Porter S, O'Sullivan JM, Santin O, Prue G.

Psychooncology. 2016 Nov 15. doi: 10.1002/pon.4311. [Epub ahead of print]

PMID:
27862602
10.

Indications, Utilization and Complications Following Prostate Biopsy: a New York State Analysis.

Halpern JA, Sedrakyan A, Dinerman B, Hsu WC, Mao J, Hu JC.

J Urol. 2016 Nov 14. pii: S0022-5347(16)31785-2. doi: 10.1016/j.juro.2016.11.081. [Epub ahead of print]

PMID:
27856226
11.

Urinary Diversion for Severe Urinary Adverse Events of Prostate Radiation: Results from a Multi-Institutional Study.

Bassett MR, Santiago-Lastra Y, Stoffel JT, Goldfarb R, Elliott SP, Pate SC, Broghammer JA, Gaither T, Breyer BN, Vanni AJ, Voelzke BB, Erickson BA, McClung CD, Presson AP, Tward JD, Myers JB; Neurogenic Bladder Research Group.; Trauma and Urologic Reconstructive Network of Surgeons..

J Urol. 2017 Mar;197(3 Pt 1):744-750. doi: 10.1016/j.juro.2016.10.091.

PMID:
27810450
12.

Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.

Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM Jr, Wagner AA, Wei JT, Lin DW.

J Urol. 2016 Nov 1. pii: S0022-5347(16)31634-2. doi: 10.1016/j.juro.2016.10.090. [Epub ahead of print]

PMID:
27810448
13.

Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.

Thomsen FB, Folkvaljon Y, Brasso K, Loeb S, Robinson D, Egevad L, Stattin P.

J Surg Oncol. 2016 Nov;114(6):664-670. doi: 10.1002/jso.24408.

PMID:
27511833
14.
15.

Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.

Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS.

J Urol. 2016 Dec;196(6):1613-1618. doi: 10.1016/j.juro.2016.06.079.

PMID:
27320841
16.
17.

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

Carlsson SV, de Carvalho TM, Roobol MJ, Hugosson J, Auvinen A, Kwiatkowski M, Villers A, Zappa M, Nelen V, Páez A, Eastham JA, Lilja H, de Koning HJ, Vickers AJ, Heijnsdijk EA.

Cancer. 2016 Nov 15;122(21):3386-3393. doi: 10.1002/cncr.30192.

PMID:
27459245
18.

Association between radical prostatectomy and risk of herpes zoster.

Hsu CY, Chen PR, Chen HJ, Liang JA.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):337-342. doi: 10.1007/s10096-016-2806-6.

PMID:
27752790
19.

Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR.

J Urol. 2016 Nov;196(5):1408-1414. doi: 10.1016/j.juro.2016.06.086.

PMID:
27352635
20.

Health Care Integration and Quality among Men with Prostate Cancer.

Herrel LA, Kaufman SR, Yan P, Miller DC, Schroeck FR, Skolarus TA, Shahinian VB, Hollenbeck BK.

J Urol. 2017 Jan;197(1):55-60. doi: 10.1016/j.juro.2016.07.040.

PMID:
27423758
Items per page

Supplemental Content

Loading ...
Support Center